Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from AztraZeneca

17:14 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "AztraZeneca" found in our extensive news archives from over 250 global news sources.

More Information about AztraZeneca on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about AztraZeneca for you to read. Along with our medical data and news we also list AztraZeneca Clinical Trials, which are updated daily. BioPortfolio also has a large database of AztraZeneca Companies for you to search.

Showing News Articles 1–25 of 418 from AztraZeneca

Tuesday 11th December 2018

Our #CaReMe approach to cardiovascular, renal and metabolic (#CVRM) care is a big undertaking involving players across the healthcare spectrum. We’re up for the task. Watch to see how we’re doing it. #LetsCompleteThePicturepic.twitter.com/HltD1d79P2

Our #CaReMe approach to cardiovascular, renal and metabolic ( #CVRM) care is a big undertaking involving players across the healthcare spectrum. We’re up for the task. Watch to see how we’re doing it. #LetsCompleteThePicture

BRCA mutations are found in 60% of all inherited #breastcancer cases. As these forms of cancer can develop earlier in younger patients, early testing and diagnosis is crucial #bcsm #SABCS18pic.twitter.com/F4o5C7nk7o

BRCA mutations are found in 60% of all inherited #breastcancer cases. As these forms of cancer can develop earlier in younger patients, early testing and diagnosis is crucial #bcsm #SABCS18 pic.twitter.com/F4o5C7nk7o

Mutations to the BReast CAncer susceptibility (BRCA) gene increase the risk of cancer as they make cells unable to fix some DNA damage. #bcsm #SABCS18pic.twitter.com/PYH503oVj0

Mutations to the BReast CAncer susceptibility (BRCA) gene increase the risk of cancer as they make cells unable to fix some DNA damage. #bcsm #SABCS18 pic.twitter.com/PYH503oVj0

#ImmunoOncology seeks to strengthen the body’s natural ability to protect itself by providing the immune system with tools to help fight #cancerpic.twitter.com/DjGqaF4NA0

#ImmunoOncology seeks to strengthen the body’s natural ability to protect itself by providing the immune system with tools to help fight #cancer pic.twitter.com/DjGqaF4NA0

Knowing the functional genomic drivers of disease could enable us to more accurately select the right drug targets and increase the probability of success in the clinic. Find out more about our recent launch of the Functional Genomics Centre: http://bit.

Knowing the functional genomic drivers of disease could enable us to more accurately select the right drug targets and increase the probability of success in the clinic. Find out more about our recent launch of the Functional Genomics Centre: http://bit.ly/2Pv9aT1 . pic.twitter.com/QcutMilG9X

We created the #CaReMe approach because we saw a need to address cardiovascular, renal and metabolic (#CVRM) diseases in a more holistic way. Listen to Danilo Vergo, VP CVRM Global Medical Affairs, and learn more here: http://bit.ly/2pAQDtM . #LetsComp

We created the #CaReMe approach because we saw a need to address cardiovascular, renal and metabolic ( #CVRM) diseases in a more holistic way. Listen to Danilo Vergo, VP CVRM Global Medical Affairs, and learn more here: http://bit.ly/2pAQDtM . #LetsCompleteThePicture pic.twitter

We have delivered 13 novel medicines to patients in more than 100 countries around the world since 2013, four alone in 2017.pic.twitter.com/nrH31d2n8u

We have delivered 13 novel medicines to patients in more than 100 countries around the world since 2013, four alone in 2017. pic.twitter.com/nrH31d2n8u

Monday 10th December 2018

Triple negative #breastcancer is a rarer form of breast cancer that can be more difficult to treat due to lack of receptor targets. #bcsm #SABCS18pic.twitter.com/KNusYqMgNS

Triple negative #breastcancer is a rarer form of breast cancer that can be more difficult to treat due to lack of receptor targets. #bcsm #SABCS18 pic.twitter.com/KNusYqMgNS

Identifying whether a patient’s breast cancer has particular receptors present on its cells surface, or other characteristics (such as genetics), is critical in determining the most appropriate management approach. #bcsm #SABCS18pic.twitter.com/Sc4AtfhZ

Identifying whether a patient’s breast cancer has particular receptors present on its cells surface, or other characteristics (such as genetics), is critical in determining the most appropriate management approach. #bcsm #SABCS18 pic.twitter.com/Sc4AtfhZcm

Today, we would like to congratulate Sir Gregory Winter (co-founder of CAT, now part of MedImmune), as he collects his joint Nobel Prize in Chemistry with George Smith. Their pioneering use of phage display helped to launch the first fully human therapeut

Today, we would like to congratulate Sir Gregory Winter (co-founder of CAT, now part of MedImmune), as he collects his joint Nobel Prize in Chemistry with George Smith. Their pioneering use of phage display helped to launch the first fully human therapeutic antibody. pic.twitter.com/UuRpXi1re5

Today, we announced the launch of the Functional Genomics Centre with @CRUKresearch aimed at accelerating the discovery of new cancer medicines. Find out more about our partnership: http://bit.ly/2Pv9aT1 . #FunctionalGenomics #CRISPRpic.twitter.com/6x57

Today, we announced the launch of the Functional Genomics Centre with @CRUKresearch aimed at accelerating the discovery of new cancer medicines. Find out more about our partnership: http://bit.ly/2Pv9aT1 . #FunctionalGenomics #CRISPR pic.twitter.com/6x57F2imq0

Which symptoms do patients with #anaemia in #CKD most commonly highlight to their doctors? We spoke to Dr Bicheng Liu to find out more about the burden of this condition for Chinese patients.pic.twitter.com/iLTMntxcsh

Which symptoms do patients with #anaemia in #CKD most commonly highlight to their doctors? We spoke to Dr Bicheng Liu to find out more about the burden of this condition for Chinese patients. pic.twitter.com/iLTMntxcsh

Friday 7th December 2018

BRCA mutations are linked to an increased risk of #prostatecancer, as well as other cancers. BRCA is needed to repair DNA damage – this damage increases the risk of cells growing as cancer cells. #pcsm #SABCSpic.twitter.com/dBxtxvZkzS

BRCA mutations are linked to an increased risk of #prostatecancer, as well as other cancers. BRCA is needed to repair DNA damage – this damage increases the risk of cells growing as cancer cells. #pcsm #SABCS

Why is #anaemia such a serious complication for #CKD patients? We spoke to Dr Bicheng Liu, Professor of Nephrology at Southeast University Nanjing, to help us understand more.pic.twitter.com/aEHxGRoywi

Why is #anaemia such a serious complication for #CKD patients? We spoke to Dr Bicheng Liu, Professor of Nephrology at Southeast University Nanjing, to help us understand more. pic.twitter.com/aEHxGRoywi

Thursday 6th December 2018

Using genetic testing for BRCA is important for carriers of both sexes for understanding familiar risk. BRCA mutations not only increase the risk of various cancers in both men and women but also has an equal chance of being passed onto their children. #p

Using genetic testing for BRCA is important for carriers of both sexes for understanding familiar risk. BRCA mutations not only increase the risk of various cancers in both men and women but also has an equal chance of being passed onto their children. #pcsm #bcsm #ocsm

70% of our innovative medicine pipeline was discovered or developed in the #UKpic.twitter.com/r1uZYvFicB

70% of our innovative medicine pipeline was discovered or developed in the #UK pic.twitter.com/r1uZYvFicB

Today on LabTalk, Nicolas Guzman, M.D., Director, Nephrology Clinical Research, explains the need for better, proactive discussions about #anaemia in CKD, drawing on insights from our latest patient survey of patients with #CKD. Read the blog here: http:

Today on LabTalk, Nicolas Guzman, M.D., Director, Nephrology Clinical Research, explains the need for better, proactive discussions about #anaemia in CKD, drawing on insights from our latest patient survey of patients with #CKD. Read the blog here: http://bit.ly/2AR8pyh .

Wednesday 5th December 2018

Combination strategies in #cancer are treatment options that combine 2 or more therapeutic agents. Such regimens are a key area of clinical research that may further unlock the potential of #ImmunoOncologypic.twitter.com/DvOrmcWybr

Combination strategies in #cancer are treatment options that combine 2 or more therapeutic agents. Such regimens are a key area of clinical research that may further unlock the potential of #ImmunoOncology pic.twitter.com/DvOrmcWybr

Very excited to see the energy, proposals and commitment of the 7 academic sites of @MedImmune @AstraZeneca partner of choice initiativepic.twitter.com/pcfogYoVcY

Very excited to see the energy, proposals and commitment of the 7 academic sites of @MedImmune @AstraZeneca partner of choice initiative pic.twitter.com/pcfogYoVcY

We have announced the results of a patient survey into #anaemia in #CKD. The findings suggest a need for greater attention to this potentially serious complication of kidney disease. Find out more: http://bit.ly/2AR8pyh .pic.twitter.com/zPVPZOsW8E

We have announced the results of a patient survey into #anaemia in #CKD. The findings suggest a need for greater attention to this potentially serious complication of kidney disease. Find out more: http://bit.ly/2AR8pyh . pic.twitter.com/zPVPZOsW8E

We’re revealing more secrets to successful partnering. Have an idea you’d like to partner with us on? Don’t miss our latest video: ‘Ensuring partnership success through post-deal management’. Find out more: http://bit.ly/2CsOxoq .pic.twitter.c

We’re revealing more secrets to successful partnering. Have an idea you’d like to partner with us on? Don’t miss our latest video: ‘Ensuring partnership success through post-deal management’. Find out more: http://bit.ly/2CsOxoq . pic.twitter.com/GUFEasQhUO

A vote of confidence in UK industry today as @GregClarkMP announces a new Life Sciences Sector Deal – creating high skilled jobs with £1.3bn of private and public sector investment in innovative treatments and technologies #IndustrialStrategy http://

A vote of confidence in UK industry today as @GregClarkMP announces a new Life Sciences Sector Deal – creating high skilled jobs with £1.3bn of private and public sector investment in innovative treatments and technologies #IndustrialStrategy http://socsi.in/JS15G  pic.twitter.com/kjuYWHht1t

On International Volunteer Day, we’d like to thank our employees who have volunteered >29,000 hours on projects around the world. Find out more about how we aim to make a positive impact on our local communities: http://bit.ly/2zGsp78 . #IVD2018pic.tw

On International Volunteer Day, we’d like to thank our employees who have volunteered >29,000 hours on projects around the world. Find out more about how we aim to make a positive impact on our local communities: http://bit.ly/2zGsp78 . #IVD2018 pic.twitter.com/CYNGWUTjJT

Tuesday 4th December 2018

What an inspiring week at #ASH18! Hear from AstraZeneca’s Vice President of US Oncology, Olivier Nataf, on the importance of medical congresses for scientific discovery in #bloodcancer.pic.twitter.com/ro93GTjEr6

What an inspiring week at #ASH18! Hear from AstraZeneca’s Vice President of US Oncology, Olivier Nataf, on the importance of medical congresses for scientific discovery in #bloodcancer. pic.twitter.com/ro93GTjEr6

The International Future Healthcare Forum we hosted this week attracted 70+ delegates from our International bio-hubs. Listen to Leon Wang, Executive Vice President, AstraZeneca International and Country President, China, speak about his personal highligh

The International Future Healthcare Forum we hosted this week attracted 70+ delegates from our International bio-hubs. Listen to Leon Wang, Executive Vice President, AstraZeneca International and Country President, China, speak about his personal highlights from the event. pic.twitter.com/rMLXA99M87


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks